Whereas both MPO- and PR3-ANCA+ patients can have lung involvement, those who are MPO-ANCA+ more often present with features of interstitial lung disease (e.g., fibrosing lung disease) rather than cavitary lesions and/or nodules characteristic of PR3-ANCA+ disease (44, 45). Here, PRTN3 is linked to lung disorder.